Urgent National Drug Shortage

Posted in Latest News on October 16, 2017.

The Department of Health was alerted that Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays and Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.

You can read more about these shortages at:

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=860 (for lidocaine with epinephrine)

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=937 (for bupivacaine with epinephrine



More Latest News

ALERT: Mandatory CE on Controlled Substances must be Board approved
June 4, 2018

Click here for information on Board approved courses that meet the new 2-hour CE requirements for Controlled Substance Prescribing Providers Continue reading


Take Control of Controlled Substances
May 7, 2018

Click Here to be in the know on how Florida’s new legislation on controlled substances affects you Continue reading